Page 1078 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1078
Chapter 70
REFERENCES
1. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial 14. Samonis G, Gikas A, Anaissie EJ, et al. Prospective evaluation
bloodstream infections in US hospitals: analysis of 24,179 cases of effects of broad-spectrum antibiotics on gastrointestinal
from a prospective nationwide surveillance study. Clin Infect yeast colonization of humans. Antimicrob Agents Chemother.
Dis. 2004;39:309-317. 1993;32:51-53.
2. Leon C, Alvarez-Lerma F, Ruiz-Santans S, et al. Fungal coloniza- 15. Mermel LA, Allon M, Bouzo E, et al. Clinical practice guidelines
tion and/or infection in non-neutropenic critically ill patients: for the diagnosis and management of intravascular catheter-
results of the EPCAN observational study. Eur J Clin Microbiol related infection: 2009 update by the Infectious Diseases Society
Infect Dis. 2009;28:233-242. of America. Clin Infect Dis. 2009;49:1-45.
3. Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attrib- 16. Kauffman CA. Candiduria. Clin Infect Dis. 2005;41:S371-S376.
utable outcomes of candidemia in adults and children hospital- 17. Barkauskas CE, Perfect JR. Candida pneumonia: what we know
ized in the United States: a propensity analysis. Clin Infect Dis. and what we don’t. Curr Fungal Infect Rpt. 2009;3:21-31.
2005;41:1232-1239.
18. Pertowski CA, Baron RC, Lasker BA, et al. Nosocomial outbreak
4. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of Candida albicans sternal wound infections following cardiac
of sepsis and infection in ICU patients from an international surgery traced to a scrub nurse. J Infect Dis. 1995;172:817.
multicentre cohort study. Intensive Care Med. 2002;28:108-121.
19. Sanchez V, Vazquez JA, Barth-Jones D, et al. Nosocomial acqui-
5. Pfaller MA, Diekema DJ. Epidemiology of invasive candi- sition of Candida parapsilosis: an epidemiological study. Am J
diasis: a persistent public health problem. Clin Microbiol Rev. Med. 1993;94:577-582.
2007;20:133-163.
20. Malani PN, McNeil SA, Bradley SF, Kauffman CA. Candida
6. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National albicans sternal wound infections: a chronic and recurrent com-
epidemiology of mycoses survey (NEMIS): variations in rates of plication of median sternotomy. Clin Infect Dis. 2002;35:1316.
bloodstream infections due to Candida species in seven surgical
intensive care units and six neonatal intensive care units. Clin 21. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis,
Infect Dis. 1999;29:253-258. an emerging fungal pathogen. Clin Microbiol Rev. 2008;21:
606-625.
7. Bouza E, Munoz P. Epidemiology of candidemia in intensive
care units. Internat J Antimicrob Agents. 2008;32:S87-S91. 22. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for
candidal bloodstream infections in surgical intensive care unit
8. Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candi- patients: the NEMIS prospective multicenter study. Clin Infect
demia-related hospitalization in the United States, 2000-2005. Dis. 2001;33:177-186.
Infect Control Hosp Epidemiol. 2008;29:978-980.
23. Pappas PG, Rex JH, Lee J, et al. A prospective observational
9. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida spe- study of candidemia: epidemiology, therapy, and influences on
cies infections in critically ill non-immunosuppressed patients. mortality in hospitalized adult and pediatric patients. Clin Infect
Lancet Infect Dis. 2003;3:685-702. Dis. 2003;37:634-643.
10. Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergil- 24. Shorr AF, Lazarus DR, Sherner JH, et al. Do clinical features
losis in the intensive care unit. Clin Infect Dis. 2007, 45:205-216. allow for accurate prediction of fungal pathogenesis in blood-
11. Khasawneh F, Mohamed T, Moughrabieh MK, et al. Isolation of stream infections? Potential implications of the increasing
Aspergillus in critically ill patients: a potential marker of poor prevalence of non-albicans candidemia. Crit Care Med. 2007:
outcome. J Crit Care. 2006;21:322-327. 35:1077-1083.
12. Pfaller MA. Nosocomial candidiasis: emerging spe- 25. Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology
cies, reservoirs, and modes of transmission. Clin Infect Dis. of candidemia: 3-year results from the emerging infections and
1996;22:S89-S94. the epidemiology of Iowa organisms study. J Clin Microbiol.
13. Wright WL, Wenzel RP. Nosocomial Candida. epidemiol- 2002;40:1298-1302.
ogy, transmission, and infection. Infect Dis Clin North Am. 26. Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk fac-
1997;11:411-425. tors, and outcomes of Candida albicans versus non-albicans
Section05-O-ref.indd 1 1/20/2015 4:51:22 PM

